Synthesis of Ambroxol Hydrochloride API and Consistency Evaluation of Injection (Full Set of Impurity Reference Standards)
Ambroxol Hydrochloride Injection Consistency Evaluation
Ambroxol Hydrochloride
Originator: Boehringer Ingelheim, Germany, Shumutan
Specification: 2 ml: 15 mg
Prescription:
API: Ambroxol Hydrochloride
Excipients: Sodium Chloride, Citric Acid Monohydrate, Disodium Hydrogen Phosphate Dihydrate, Water for Injection (nitrogen-filled)
Indications:
Suitable for acute and chronic lung diseases with abnormal sputum secretion and poor expectoration function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, and expectorant treatment for bronchial asthma. Preventive treatment of postoperative pulmonary complications.
Treatment of Infant Respiratory Distress Syndrome (IRDS) in premature and newborn infants.
Impurity Studies:
